High-dose transdermal estrogen, corticotropin-releasing hormone, and postnatal depression [4]

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 2, 1997, Pages 704-

  Cizza, G ^a   Gold, P W ^a   Chrousos, G P ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ESTRADIOL; ESTROGEN; HYDROCORTISONE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEMALE; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LETTER; PRIORITY JOURNAL; PUERPERAL DEPRESSION; THIRD TRIMESTER PREGNANCY; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; CORTICOTROPIN-RELEASING HORMONE; DEPRESSION, POSTPARTUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; HUMANS;

EID: 0031025540     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)